Ali Rafat: Targeting the Inflammatory Engine of Myeloproliferative Neoplasms
Ali Rafat, Assistant Professor of Anatomical Sciences at Kashan University of Medical Sciences, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Cancers, adding:
“I am delighted to share that our article, ‘Inflammatory and Immune Microenvironment in Myeloproliferative Neoplasms: Pathogenic Mechanisms and Therapeutic Opportunities,’ has been published in the journal of Cancers.
In this review, we explore the complex interplay between chronic inflammation, immune dysregulation, and clonal evolution in Philadelphia-negative myeloproliferative neoplasms, including polycythemia vera, essential thrombocythemia, and primary myelofibrosis.
We discuss how driver mutations involving JAK2, CALR, and MPL contribute not only to abnormal hematopoietic signaling but also to the establishment of a persistent inflammatory microenvironment.
This inflammatory and immune landscape plays an important role in disease progression, bone marrow fibrosis, thrombosis, splenomegaly, and leukemic transformation.
The review also highlights alterations in both innate and adaptive immunity, including impaired T- and B-cell function, abnormal natural killer cell maturation, and the accumulation of immunosuppressive myeloid-derived suppressor cells.
Furthermore, we discuss the limitations of current therapeutic strategies and emerging opportunities to target the inflammatory and immune mechanisms underlying MPN progression.
We hope that this work will contribute to a better understanding of the dynamic relationship between malignant hematopoietic clones and their microenvironment and support the development of more effective, disease-modifying therapeutic strategies for patients with MPNs.
We sincerely thank all co-authors and collaborators for their valuable contributions to this work.”
Title: Inflammatory and Immune Microenvironment in Myeloproliferative Neoplasms: Pathogenic Mechanisms and Therapeutic Opportunities
Authors: Faride Kaikavoosnejad, Ali Keyhani, Seyyede Sepide Ashraf Moosavi, Milad Verdi, Mohammad Sepehr Yazdani, Khadijeh Dizaji Asl, Zeinab Mazloumi, Hamed Mirzaei, Ali Rafat, Reza Nejati
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 23, 2026, 15:23Katerina Pavenski: What’s New in the 2025 AABB and ICTMG Guidelines?
-
Aug 23, 2026, 15:14Denis Nikolov: A Call for Routine UACR Assessment in High-Risk Cardiovascular Patients
-
Aug 23, 2026, 15:1310 Posts Not to Miss This Week
-
Aug 23, 2026, 14:52Alejandro González Veliz: How Plaque Morphology Shapes PCI Outcomes
-
Aug 23, 2026, 14:16Vikram Sinai Talaulikar: Age-Dependent Long-Term Outcomes of Postmenopausal Hormone Replacement Therapy
-
Aug 23, 2026, 14:10Intravenous Arginine Fails to Reduce Acute Sickle Cell Pain – JAMA
-
Aug 23, 2026, 14:00Mohd Ashhad: What Should Be Done Immediately When a Blood Transfusion Reaction Occurs?
-
Aug 23, 2026, 13:56Strengthening Haemophilia Care Through National Guidelines in Kenya – Kenya Haemophilia Association
-
Aug 23, 2026, 13:52Tarek Kammoun: Case of the Day – Superior Vena Cava Thrombectomy